Andere talen Chimeric Therapeutics Limited

Aandelen

CHM

AU0000121576

Beurs gesloten - Australian S.E. Andere beurzen 08:10:52 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,019 ^AUD	+5,56%		-13,64%	-45,71%

22/05	Chimeric Therapeutics' eerste humane CHM CDH17 studie opent voor inschrijving; aandelen stijgen 4%.	MT
02/05	Chimeric Therapeutics benoemt COO; Aandelen stijgen 4%	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4%	22/05
Chimeric Therapeutics Appoints COO; Shares Rise 4%	02/05
Chimeric Therapeutics' CEO/Managing Director Steps Down; Shares Plunge 20%	01/05
Chimeric Therapeutics Obtains Patent Application Covering CORE-NK Technology; Shares Up 3%	05/04
Chimeric Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial	08/02
Chimeric Therapeutics Receives AU$7 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	10/01
Chimeric Therapeutics Secures AU$1 Million via Share Placement Deal	04/01
Chimeric Therapeutics Extends Closing Date of AU$10 Million Entitlement Offer	15/11
Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101	31-10-23
Australian Shares Rebound Ahead of US Fed Policy Meeting	31-10-23
US FDA Gives Green Signal to Chimeric Therapeutics' IND Application for Gastrointestinal Cancer Drug; Shares Jump 65%	31-10-23
Chimeric Therapeutics to Raise AU$10 Million from Entitlement Offer	25-10-23
Chimeric Therapeutics Signs Deal to Support Leukemia Trial	13-09-23
Chimeric Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31-08-23
Chimeric Therapeutics Limited Announces Board Changes	30-08-23
Chimeric Therapeutics Limited Announces the Resignation of George Matcham as Non-Executive Director	03-08-23
Chimeric Therapeutics Limited Announces Board Changes	12-07-23
Chimeric Therapeutics Secures Up to AU$12.6 Million for Clinical Trial, Therapy	23-06-23
Chimeric Therapeutics Completes Share Purchase Plan; Shares Rise 6%	23-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Chimeric Therapeutics Limited

Aandelen

CHM

AU0000121576

Andere talen

Filters